A state wide progestogen promotion program in Ohio

Obstetrics and Gynecology

Volumn 129, Issue 2, 2017, Pages 337-346

  Iams, Jay D ^a   Applegate, Mary S ^a   Marcotte, Michael P ^a   Rome, Martha ^a   Krew, Michael A ^a   Bailit, Jennifer L ^a   Kaplan, Heather C ^a   Poteet, Jessi ^a   Nance, Melissa ^a   McKenna, David S ^a   Walker, Hetty C ^a   Nobbe, Jennifer ^a   Prasad, Lakshmi ^a   Macaluso, Maurizio ^a   Lannon, Carole ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GESTAGEN; HYDROXYPROGESTERONE CAPROATE;

ARTICLE; FEMALE; HEALTH CARE PERSONNEL; HOSPITAL; HUMAN; MAJOR CLINICAL STUDY; MEDICAID; OHIO; PREGNANCY; PREMATURE LABOR; PRESCRIPTION; PRIORITY JOURNAL; RISK FACTOR; SUPPLEMENTATION; TOTAL QUALITY MANAGEMENT; ADULT; AFRICAN AMERICAN; EVALUATION STUDY; GESTATIONAL AGE; HEALTH PROMOTION; PREMATURE BIRTH; PROCEDURES; PROGRAM EVALUATION; STATISTICS AND NUMERICAL DATA; UNITED STATES;

ADULT; AFRICAN AMERICANS; FEMALE; GESTATIONAL AGE; HEALTH PROMOTION; HOSPITALS, MATERNITY; HUMANS; MEDICAID; OHIO; PREGNANCY; PREMATURE BIRTH; PROGESTINS; PROGRAM EVALUATION; UNITED STATES;

EID: 85009401612     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: 10.1097/AOG.0000000000001841     Document Type: Article

References (18)

1. Mathews TJ, MacDorman MF, Thoma ME. Infant mortality statistics from the 2013 period linked birth/infant death data set. National Vital Statistics Reports. Vol. 64, No. 9 Hyattsville (MD): National Center for Health Statistics; 2015
2. Society for Maternal-Fetal Medicine Publications Committee, with assistance of Vincenzo Berghella. Progesterone and preterm birth prevention: translating clinical trials data into clinical practice [published erratum appears in Am J Obstet Gynecol 2013;208:86]. Am J Obstet Gynecol 2012;206:376-86
3. Prediction and prevention of preterm birth. Practice Bulletin No. 130. American College of Obstetricians and Gynecologists. Obstet Gynecol 2012;120:964-73
4. Fonseca EB, Bittar RE, Carvalho MH, Zugaib M. Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: a randomized placebo-controlled double-blind study. Am J Obstet Gynecol 2003;188:419-24
5. Meis PJ, Klebanoff M, Thom E, Dombrowski MP, Sibai B, Moawad AH, et al. Prevention of recurrent preterm delivery by 17-alpha-hydroxyprogesterone caproate. N Engl J Med 2003;348:2379-85
6. Fonseca EB, Celik E, Parra M, Singh M, Nicolaides KH; Fetal Medicine Foundation Second Trimester Screening Group. Progesterone and the risk of preterm birth among women with a short cervix. N Engl J Med 2007;357:462-9
7. Hassan SS, Romero R, Vidyadhari D, Fusey S, Baxter JK, Khandelwal M, et al. Vaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix: a multicenter, randomized, double-blind, placebo-controlled trial. Ultrasound Obstet Gynecol 2011;38:18-31
8. Kilo CM. A framework for collaborative improvement: lessons from the Institute for Healthcare Improvement's Breakthrough Series. Qual Manag Health Care 2001;6:1-13
9. The Breakthrough Series: IHI's collaborative model for achieving breakthrough improvement. IHI Innovation Series white paper. Boston (MA): Institute for Healthcare Improvement; 2003. Available at: www.ihi.org/resources/Pages/IHIWhite Papers/TheBreakthroughSeriesIHIsCollaborativeModelforAch ievingBreakthroughImprovement.aspx
10. Bisognano M, Cherouny PH, Gullo S. Applying a sciencebased method to improve perinatal care: the institute for healthcare improvement perinatal improvement community. Obstet Gynecol 2014;124:810-4
11. HHS.gov.Office for Human Research Protections. Frequently asked questions. Available at: http://www.hhs.gov/ohrp/regulations-andpolicy/ guidance/faq/index.html. Retrieved April 30, 2016
12. Ohio Perinatal Quality Collaborative. 39-weeks dissemination &birth registry accuracy project. Available at: https://opqc.net/ projects/39%20wks%20BA. Retrieved April 30, 2016
13. Conde-Agudelo A, Romero R. Vaginal progesterone to prevent preterm birth in pregnant women with a sonographic short cervix: clinical and public health implications. Am J Obstet Gynecol 2016;214:235-42
14. Ohio Perinatal Quality Collaborative. Birth registry accuracy. Available at: https://opqc.net/projects/BirthRegistryAccuracy Resources. Retrieved May 2, 2016
15. Moen R, Nolan T, Provost L. Quality improvement through planned experimentation. New York (NY): McGraw-Hill; 1999
16. Perla RJ, Provost LP, Murray SK. The run chart: a simple analytical tool for learning from variation in healthcare processes. BMJ Qual Saf 2011;20:46-51
17. Hamilton BE, Martin JA, Osterman MJK, Curtin SC, Mathews TJ. Births: final data for 2014. National Vital Statistics Reports. Vol. 64, No 12. Hyattsville (MD): National Center for Health Statistics; 2015
18. Conde-Agudelo A, Romero R, Nicolaides K, Chaiworapongsa T, O'Brien JM, Cetingoz E, et al. Vaginal progesterone vs. cervical cerclage for the prevention of preterm birth in women with a sonographic short cervix, previous preterm birth, and singleton gestation: a systematic review and indirect comparison meta-analysis. Am J Obstet Gynecol 2013;208:42. e1-42. e18